PHARMAGREEN BIOTECH INC. Derivative Asset, Fair Value, Gross Liability
PHARMAGREEN BIOTECH INC. had Derivative Asset, Fair Value, Gross Liability of $271.39 thousand as of 2022-09-30, per its 10-K filed 2023-01-17.
Discontinued › Notes › Offsetting
us-gaap:DerivativeAssetFairValueGrossLiability · last filed 2023-01-17
- 2022-09-30: Derivative Asset, Fair Value, Gross Liability $271.39K.
- 2022-03-31: Derivative Asset, Fair Value, Gross Liability $816.66K.
- 2021-12-31: Derivative Asset, Fair Value, Gross Liability $237.73K.
- 2021-09-30: Derivative Asset, Fair Value, Gross Liability $472.00K.
| Period end | Derivative Asset, Fair Value, Gross Liability |
|---|---|
| 2022-09-30 | $271.39K 10-K · filed 2023-01-17 |
| 2022-03-31 | $816.66K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $237.73K 10-Q · filed 2022-02-22 |
| 2021-09-30 | $472.00K 10-K · filed 2023-01-17 |
| 2021-06-30 | $298.30K 10-Q · filed 2021-08-18 |
| 2020-09-30 | $1.38M 10-K · filed 2021-12-29 |